683210login-checkFDA approves first IV iron replacement therapy for heart failure |
Fact checked by Erik Swain
The FDA approved the first IV ferric carboxymaltose injection for iron deficiency in adults with heart failure to improve exercise capacity, according to a press release from American Regent.
The IV iron injection (Injectafer, Daiichi Sankyo/American Regent) is approved for people with New York Heart Association class II/III HF, defined as patients with a slight or marked limitation of their physical activity due to fatigue, palpitation and/or dyspnea. Read the full article in Healio.
683210login-checkFDA approves first IV iron replacement therapy for heart failure |